Discover how our integrated approach to analysing world Healthcare markets gives you the insight you need to inform critical decisions.


Stada's Outlook And Presence To Change

Stada Arzneimittel has reported further sales increases in FY17; however, this has come against a backdrop of an increasingly challenging domestic generic market and difficulties in other key markets. Stada's outlook is going to change; the firm's new management, introduced after Stada was acquired, has indicated restructuring ahead, including a renewed focus on biosimilar development. Geographically, the company will also alter its outlook to include the markets of the Middle East and North Africa, an area where Stada's current presence is very limited. Successful developments will help to offset the challenges presented by existing markets.

Stada Arzneimittel has reported further sales




The Year Ahead: Pharma & Healthcare in 2018


Kaushal Shah

Head of Pharmaceuticals and Healthcare Research
Pharmaceuticals & Healthcare | London

Jamie Davies

Head of Pharmaceuticals, Medical Devices and Healthcare Research
Pharmaceuticals & Healthcare | London

Sakshi Sikka

Pharmaceuticals and Healthcare Analyst
Pharmaceuticals & Healthcare | Singapore

Craig Smith

Pharmaceuticals & Healthcare Analyst
Pharmaceuticals & Healthcare | London


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.